.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

The Evolving Treatment Paradigm for Stage I-IIIB NSCLC

EP. 1: Dr Tsuboi on Updated Survival Results of the ADAURA Trial in Resectable NSCLC

July 29th 2023

Masahiro Tsuboi, MD, discusses the updated survival results of the phase 3 ADAURA trial in resectable EGFR-mutant non–small cell lung cancer.

EP. 2: Dr Wakelee on Key Trials With Perioperative Immunotherapy in Early-Stage NSCLC

August 4th 2023

Heather Wakelee, MD, FASCO, discusses the clinical significance of updated data from several key trials evaluating perioperative immunotherapy in early-stage non–small cell lung cancer.

EP. 3: Perioperative Trials Add to Growing Immunotherapy Landscape in Early-Stage NSCLC

August 31st 2023

Emerging data continue to shape perioperative therapy decisions for patients with early-stage non–small cell lung cancer.